UTC-based biotech company Truvian has received FDA approval for its new blood testing machine, allowing routine blood testing to happen conveniently at the doctor's office rather than at a lab.

A new article outlines a new tool that measures blood inflammation as a marker for poor CAR T therapy outcomes. Researchers with City of Hope, one of the largest and most advanced cancer research and ...